IGM Biosciences Inc reports results for the quarter ended in June - Earnings Summary

IGM Biosciences

07/08/2023 13:01

* IGM Biosciences Inc  IGMS.OQ  reported a quarterly
adjusted loss
of $1.43​​ per share for the quarter ended in June. The mean
expectation of ten analysts for the quarter was for a loss of
$1.43 per share.
    * Revenue rose 22.4% to $448.00 thousand from a year ago;
analysts
expected $797.60 thousand. 
    * IGM Biosciences Inc's reported EPS for the quarter was a
loss of
$1.43​.
    * The mean earnings estimate of analysts had risen by
about 1.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * IGM Biosciences Inc shares had fallen by 1.8% this
quarter and
lost 46.7% so far this year.
    * The company reported a quarterly loss of $64.42 million.
    * Wall Street's median 12-month price target for IGM
Biosciences
Inc is $22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 12:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.43          -1.43          Met
 Mar. 31 2023      -1.36          -1.33          Beat
 Dec. 31 2022      -1.25          -1.19          Beat
 Sep. 30 2022      -1.43          -1.32          Beat